• Share
  • Email
  • Print

Robert M. Tammero

Fax +1.617.261.3175
Rob Tammero is an associate in the firm’s Boston office. Mr. Tammero represents companies in a range of corporate and transactional matters, including mergers and acquisitions, debt and equity financings, and corporate governance. Mr. Tammero’s practice includes representation of banks and other financial institutions in corporate and regulatory matters.

Professional Background

Prior to joining the firm, Mr. Tammero was an associate in the corporate and securities section of a national, Boston-based law firm. Before entering private practice, Mr. Tammero served as a law clerk with the Federal Deposit Insurance Corporation.

Professional/Civic Activities

  • Boston Bar Association, Banking Committee Co-Chair, 2012- 2014
  • American Bar Association Presidential Task Force on Financial Markets Regulatory Reform, Assistant Reporter, 2011- 2012
  • Big Brothers Big Sisters of Massachusetts Bay, 2008-Present
  • Salem Five Bancorp in its acquisition of Georgetown Bancorp (NASDAQ: GTWN)
  • Springstone Financial, LLC, an arranger of patient financing for medical and dental procedures, in its sale to LendingClub Corporation (NYSE: LC)
  • Brooks Automation, Inc. (NASDAQ: BRKS) in its acquisition of cooling and freezing technology from BioCision, LLC
  • inviCRO, LLC, a medical imaging company, in its acquisition of Molecular NeuroImaging, LLC
  • Next Generation Children’s Centers, a provider of early education and childcare, in its sale to Cadence Education, Inc., an Audax Group portfolio company
  • Tarpon Biosystems, Inc., a developer of continuous processing technology, in its sale to Pall Corporation (NYSE: PLL)
  • Giant Glass Company Inc. in its sale to Safelite AutoGlass
  • Spero Therapeutics, LLC in venture financings and its acquisition of pharmaceutical candidates from Pro Bono Bio
  • Quabbin Capital Inc. in its acquisition of bankruptcy assets of the Upper Crust Pizzeria restaurant chain
  • Hemoglobin Oxygen Therapeutics, LLC in its financing and acquisition of bankruptcy assets of OPK Biotech, LLC
  • RA Capital Management, LLC in several venture capital financings of life sciences companies, including Aclaris, Inc. (NASDAQ: ACRS) and Arvinas, Inc.
  • Numerous emerging growth companies and start-ups in connection with their organization, operation, governance, and financing
  • Numerous New England banks and other financial institutions in mergers and other corporate, transactional, and regulatory matters